The Impact of Disposables on Project Economics in a New Antibody Plant: A Case Study - A case study compares capital costs, operating expenses, and net present value for a new MAb plant. - BioPharm

ADVERTISEMENT

The Impact of Disposables on Project Economics in a New Antibody Plant: A Case Study
A case study compares capital costs, operating expenses, and net present value for a new MAb plant.


BioPharm International
Volume 22, Issue 12

CONCLUSION

This case study demonstrates that integrating disposable and stainless steel technology in a hybrid model has economic benefits. Using this approach in a 100 kg antibody production plant yielded significant savings in capital expenses, a key factor that may determine the feasibility of an investment project for a small- or medium-sized company. The economic model also showed lower operating costs for the hybrid project, compared to a project based on stainless steel, mainly as a result of lower equipment-related costs and reduced demand for pharmaceutical water. The net present value of the hybrid project, calculated over 10 years, was 68% higher than a similar project based on stainless steel technology.

ACKNOWLEDGEMENTS

We would like to thank Danilo Ponassi of Sartorius Stedim Biotech for his significant contribution to the introduction of disposable technology in CIM processes over more than 10 years.

José M. País Chanfrau is the plant design engineer, Katia Zorrilla is a chemical engineer, and Ernesto Chico is the technical director, all in the Technical Direction department at the Center of Molecular Immunology, Havana, Cuba, +53 7 271 3357,

REFERENCES

1. Farid SS, Washbrook J, Titchener-Hooker NJ. Decision-support tool for assessing biomanufacturing strategies under uncertainty: Stainless steel versus disposable equipment for clinical trial material preparation. Biotechnol Prog. 2005;21:486–97.

2. Darby N. Trends in biological manufacturing: How will our industry change in the next 10 years? 2nd Annual Bioprocess Technology Seminar & Exhibition, Europe; 2008 June 23–25; Stockholm, Sweden. Available from http://www.asmeconferences.org/BioprocessEurope08/ASMEDarby.pdf

3. Lang HJ. Simplified approach to preliminary cost estimates. Chem Eng. 1948;55:112–113.

4. Petrides D. Bioprocess design and economics. In Harrison RG, Todd PW, Rudge SR, Petrides D, editors. Bioseparations science and engineering. London: Oxford University Press; 2000.

5. Holland FA, Wilkinson JK. Process Economics. In Perry R, Green DW, Maloney JO, editors. Perry´s chemical engineers' handbook. 7th ed. New York: McGraw-Hill Co., Inc.; 1999.

6. Sinclair A, Monge M. How to evaluate the cost impact of using disposables in biomanufacturing. Biopharm Int. 2008; 1(6):26–30.


blog comments powered by Disqus

ADVERTISEMENT

Moscow Hosts IFPMA Biosimilars Conference
May 17, 2013
AbbVie and Alvine Will Collaborate on Celiac Disease Therapy
May 15, 2013
FDA Issues Pharmacoepidemiologic Safety Study Guidance
May 14, 2013
USP Launches Initiative to Fight Counterfeit Drugs in Sub-Saharan Africa
May 13, 2013
Amgen Forms New Joint Venture to Commercialize Vectibix in China
May 13, 2013
Upcoming Conferences
UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

ADVERTISEMENT

Author Guidelines
FindPharma
Source: BioPharm International,
Click here